|
|
|
|
AN ACT
|
|
relating to the practice of therapeutic optometry. |
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
SECTION 1. Subchapter E, Chapter 351, Occupations Code, is |
|
amended by adding Section 351.2034 to read as follows: |
|
Sec. 351.2034. COMPLAINTS RESULTING FROM GLAUCOMA |
|
TREATMENT. (a) The board, in collaboration with the Texas Medical |
|
Board, shall adopt rules for investigating and reviewing complaints |
|
filed with the board regarding a therapeutic optometrist's |
|
treatment of a patient for glaucoma. The rules must ensure that: |
|
(1) a person who files a complaint has the opportunity |
|
to explain the allegations made in the complaint; |
|
(2) a complaint is not dismissed without appropriate |
|
consideration by the board; |
|
(3) a complaint is resolved within six months after |
|
the date the complaint is filed; |
|
(4) the board notifies the Texas Medical Board of the |
|
receipt and disposition of a complaint; and |
|
(5) a complaint is reviewed as provided by this |
|
section. |
|
(b) After a complaint regarding a therapeutic optometrist's |
|
treatment of a patient for glaucoma is filed with the board, the |
|
board shall select at least one physician licensed in this state who |
|
specializes in ophthalmology to: |
|
(1) review the complaint and determine if the |
|
therapeutic optometrist's treatment of the patient for glaucoma |
|
violated the standard of care applicable to a physician |
|
specializing in ophthalmology; and |
|
(2) submit to the board a written report on the |
|
physician's determination. |
|
(c) If the report under Subsection (b) states that the |
|
standard of care was violated, the board shall forward the |
|
complaint and report to an expert panel appointed by the board and |
|
the Texas Medical Board. The panel must be composed of an equal |
|
number of physicians who specialize in ophthalmology and |
|
therapeutic optometrists. Each member of the expert panel must be |
|
licensed to practice medicine or therapeutic optometry, as |
|
applicable, in this state. A physician who serves on an expert |
|
panel may also serve as an expert physician for the Texas Medical |
|
Board. |
|
(d) An expert panel selected to review a complaint under |
|
Subsection (c) shall: |
|
(1) review the physician's determination made under |
|
Subsection (b); and |
|
(2) recommend to the board whether the therapeutic |
|
optometrist should be subject to disciplinary action and, if so, |
|
whether the disciplinary action should include suspension or |
|
revocation of the therapeutic optometrist's certificate issued |
|
under Section 351.3581(a). |
|
(e) A person is not eligible to review a complaint under |
|
Subsection (b) or serve on an expert panel under Subsection (c) if: |
|
(1) the person or the person's spouse is an officer, |
|
employee, or paid consultant of a Texas trade association, as |
|
defined by Section 351.053, in the field of health care; or |
|
(2) the person is a member of the faculty or board of |
|
trustees of an optometry school or an institution of higher |
|
education with an affiliated school of optometry. |
|
(f) The board shall maintain and make publicly available |
|
online: |
|
(1) information regarding the number of complaints |
|
filed with the board regarding the treatment of patients for |
|
glaucoma by therapeutic optometrists and the disposition of those |
|
complaints; and |
|
(2) a searchable list of each therapeutic optometrist |
|
whose certificate under Section 351.3581(a) was suspended or |
|
revoked by the board. |
|
(g) This section expires September 1, 2027. |
|
SECTION 2. Section 351.358(c), Occupations Code, is amended |
|
to read as follows: |
|
(c) A therapeutic optometrist may prescribe not more than |
|
[oral medications only in the following classifications of oral |
|
pharmaceuticals: |
|
[(1) one 10-day supply of oral antibiotics; |
|
[(2) one 72-hour supply of oral antihistamines; |
|
[(3) one seven-day supply of oral nonsteroidal |
|
anti-inflammatories; |
|
[(4)] one three-day supply of any medication |
|
classified as a controlled substance under Schedule [analgesic |
|
identified in Schedules] III, IV, or [and] V of 21 U.S.C. Section |
|
812[; and |
|
[(5) any other oral pharmaceutical recommended by the |
|
Optometric Health Care Advisory Committee and approved by the board |
|
and the Texas State Board of Medical Examiners]. |
|
SECTION 3. The heading to Section 351.3581, Occupations |
|
Code, is amended to read as follows: |
|
Sec. 351.3581. [DIAGNOSIS AND] TREATMENT OF GLAUCOMA. |
|
SECTION 4. Sections 351.3581(a) and (d), Occupations Code, |
|
are amended to read as follows: |
|
(a) A therapeutic optometrist may not administer or |
|
prescribe an oral or parenteral medication or treat glaucoma unless |
|
the therapeutic optometrist holds a certificate issued by the |
|
board. A therapeutic optometrist certified under this section |
|
[subsection] shall be known as an optometric glaucoma specialist. |
|
To obtain a certificate, a therapeutic optometrist must [as |
|
required under Section 351.165(c)]: |
|
(1) complete an instructional clinical review course; |
|
and |
|
(2) pass an examination approved by the board. |
|
(d) A therapeutic optometrist shall refer a patient to an |
|
ophthalmologist if: |
|
(1) the patient is younger than 16 years of age and has |
|
been diagnosed as having glaucoma; |
|
(2) the patient has been diagnosed as having acute |
|
closed angle glaucoma; |
|
(3) the patient has been diagnosed as having malignant |
|
glaucoma or neovascular glaucoma; |
|
(4) the patient has definite optic disc, retinal nerve |
|
fiber layer, or macular imaging abnormalities consistent with |
|
glaucoma and visual field abnormalities in both hemifields, or loss |
|
within five degrees of fixation in at least one hemifield as tested |
|
with standard automated perimetry [therapeutic optometrist |
|
determines that a patient's glaucoma is caused by a diabetic |
|
complication and, after joint consultation with the physician |
|
treating the diabetes and an ophthalmologist by telephone, fax, or |
|
another method, the physician or ophthalmologist determines that |
|
the patient should be seen by the physician or ophthalmologist]; or |
|
(5) the therapeutic optometrist determines that a |
|
patient's glaucoma is not responding [appropriately] to |
|
nonsurgical intervention [a treatment specified in Subsection (f) |
|
and, after consulting a physician by telephone, fax, or another |
|
method, the physician determines that the patient should be seen by |
|
the physician or an appropriate specialist]. |
|
SECTION 5. Not later than December 1, 2021, the Texas |
|
Optometry Board shall adopt rules necessary to implement the |
|
changes in law made by this Act to Chapter 351, Occupations Code. |
|
SECTION 6. Sections 351.3581(b) and (c), Occupations Code, |
|
are repealed. |
|
SECTION 7. This Act takes effect September 1, 2021. |
|
|
|
|
|
|
|
|
______________________________ |
______________________________ |
|
President of the Senate |
Speaker of the House |
|
|
I hereby certify that S.B. No. 993 passed the Senate on |
|
May 13, 2021, by the following vote: Yeas 30, Nays 0. |
|
|
|
|
______________________________ |
|
Secretary of the Senate |
|
|
I hereby certify that S.B. No. 993 passed the House on |
|
May 24, 2021, by the following vote: Yeas 144, Nays 2, one present |
|
not voting. |
|
|
|
|
______________________________ |
|
Chief Clerk of the House |
|
|
|
|
|
Approved: |
|
|
|
______________________________ |
|
Date |
|
|
|
|
|
______________________________ |
|
Governor |